Table of Contents  by unknown
Volume 19, Number 7, July 2013
IN MEMORIAM
1001 John H. Kersey, M.D.
Daniel J. Weisdorf, Bruce R. BlazarTHE BOTTOM LINE
1002 Hematopoietic Cell Transplantation in High-Risk Childhood
Acute Myelogenous Leukemia
Soheil Meshinchi1004 A Clever Person Solves a Problem; a Wise Person Avoids It
Andre Tichelli, Alicia RovoREVIEW
1006 Diagnostic and Therapeutic Advances in Blastic Plasmacytoid
Dendritic Cell Neoplasm: A Focus on Hematopoietic Cell
Transplantation
Mohamed A. Kharfan-Dabaja, Hillard M. Lazarus, Taiga Nishihori,
Rami A. Mahfouz, Mehdi HamadaniBIOLOGY
1013 Allotype Analysis to Distinguish the Origin of Varicella-Zoster
Virus Immunoglobulin G after Allogeneic Stem Cell
Transplantation
Rie Yamazaki, Hideki Nakasone, Yukie Tanaka, Miki Sato, Kiriko Terasako,
Hidenori Wada, Yuko Ishihara, Koji Kawamura, Kana Sakamoto,
Masahiro Ashizawa, Tomohito Machishima, Shun-ichi Kimura,
Misato Kikuchi, Shinya Okuda, Shinichi Kako, Junya Kanda,
Aki Tanihara, Junji Nishida, Yoshinobu KandaCLINICAL RESEARCH
1021 Allogeneic Hematopoietic Cell Transplantation in First Remission
Abrogates Poor Outcomes Associated with High-Risk Pediatric
Acute Myeloid Leukemia
Michael J. Burke, John E. Wagner, Qing Cao, Celalettin Ustun,
Michael R. Verneris1026 Efficacy and Long-Term Outcome of Treatment for Pure Red
Cell Aplasia after Allogeneic Stem Cell Transplantation from
Major ABO-Incompatible Donors
Makoto Hirokawa, Takahiro Fukuda, Kazuteru Ohashi, Michihiro Hidaka,
Tatsuo Ichinohe, Koji Iwato, Heiwa Kanamori, Makoto Murata, Toru Sakura,
Masahiro Imamura, Soichi Adachi, Ritsuro Suzuki, Yasuo Morishima,
Hisashi Sakamaki, for The PRCA Collaborative Study GroupContinued
Contents, continued1033 Cyclophosphamide followed by Intravenous Targeted Busulfan
for Allogeneic Hematopoietic Cell Transplantation:
Pharmacokinetics and Clinical Outcomes
Andrew R. Rezvani, Jeannine S. McCune, Barry E. Storer, Ami Batchelder,
Aiko Kida, H. Joachim Deeg, George B. McDonald1040 A Phase I Study of CPX-351 in Combination with Busulfan and
Fludarabine Conditioning and Allogeneic Stem Cell
Transplantation in Adult Patients with Refractory
Acute Leukemia
Usama Gergis, Gail Roboz, Tsiporah Shore, Ellen Ritchie, Sebastian Mayer,
Usama Wissa, Marshall McKenna, Paul Christos, Roger Pearse, Tomer Mark,
Joseph Scandura, Koen van Besien, Eric Feldman1046 Motivations, Experiences, and Perspectives of Bone Marrow
and Peripheral Blood Stem Cell Donors: Thematic Synthesis
of Qualitative Studies
Maria C. Garcia, Jeremy R. Chapman, Peter J. Shaw, David J. Gottlieb,
Angelique Ralph, Jonathan C. Craig, Allison Tong1059 Outcomes of Adults with Acute Lymphoblastic Leukemia Relapsing
after Allogeneic Hematopoietic Stem Cell Transplantation
Li Mei Poon, Amir Hamdi, Rima Saliba, Gabriela Rondon, Celina Ledesma,
Monique Kendrick, Muzaffar Qazilbash, Chitra Hosing, Roy B. Jones,
Uday R. Popat, Yago Nieto, Amin Alousi, Stefan Ciurea,
Elizabeth J. Shpall, Richard E. Champlin, Partow Kebriaei1065 A French Cohort of Childhood Leukemia Survivors: Impact
of Hematopoietic Stem Cell Transplantation on Health
Status and Quality of Life
Julie Berbis, Gerard Michel, Pascal Chastagner, Nicolas Sirvent,
Franc¸ois Demeocq, Dominique Plantaz, Vincent Barlogis, Audrey Contet,
Marilyne Poiree, Justyna Kanold, Claire Galambrun, Karine Baumstarck,
Herve Chambost, Pascal Auquier1073 Burden of Morbidity in 101 Year Survivors of Hematopoietic
Cell Transplantation: Report from the Bone Marrow
Transplantation Survivor Study
Can-Lan Sun, John H. Kersey, Liton Francisco, Saro H. Armenian,
K. Scott Baker, Daniel J. Weisdorf, Stephen J. Forman, Smita Bhatia1081 Relationship of Body Mass Index and Arm Anthropometry
to Outcomes after Pediatric Allogeneic Hematopoietic Cell
Transplantation for Hematologic Malignancies
Paul A. Hoffmeister, Barry E. Storer, Paula Charuhas Macris,
Paul A. Carpenter, K. Scott BakerContinued
Contents, continued1087 Phase II Study of CD4
1-Guided Pentostatin Lymphodepletion andPharmacokinetically Targeted Busulfan as Conditioning for
Hematopoietic Cell Allografting
Mohamed A. Kharfan-Dabaja, Claudio Anasetti, Hugo F. Fernandez,
Janelle Perkins, Jose L. Ochoa-Bayona, Joseph Pidala, Lia E. Perez,
Ernesto Ayala, Teresa Field, Melissa Alsina, Taiga Nishihori,
Frederick Locke, Javier Pinilla-Ibarz, Marcie Tomblyn1094 Pilot Study of Prophylactic Ex Vivo Costimulated Donor Leukocyte
Infusion After Reduced-Intensity Conditioned Allogeneic
Stem Cell Transplantation
Anita J. Kumar, Elizabeth O. Hexner, Noelle V. Frey, Selina M. Luger,
Alison W. Loren, Ran Reshef, Jean Boyer, Jacqueline Smith,
Edward A. Stadtmauer, Bruce L. Levine, Carl H. June,
David L. Porter, Steven C. Goldstein1102 Unrelated Donor Allogeneic Transplantation after Failure of
Autologous Transplantation for Acute Myelogenous Leukemia:
A Study from the Center for International Blood and Marrow
Transplantation Research
James M. Foran, Steven Z. Pavletic, Brent R. Logan, Manza A. Agovi-Johnson,
Waleska S. Perez, Brian J. Bolwell, Martin Bornh€auser, Christopher N. Bredeson,
Mitchell S. Cairo, Bruce M. Camitta, Edward A. Copelan, Jason Dehn,
Robert P. Gale, Biju George, Vikas Gupta, Gregory A. Hale, Hillard M. Lazarus,
Mark R. Litzow, Dipnarine Maharaj, David I. Marks, Rodrigo Martino,
Richard T. Maziarz, Jacob M. Rowe, Philip A. Rowlings, Bipin N. Savani,
Mary Lynn Savoie, Jeffrey Szer, Edmund K. Waller, Peter H. Wiernik,
Daniel J. Weisdorf1109 Molecular Monitoring of Minimal Residual Disease in the
Peripheral Blood of Patients with Multiple Myeloma
Mark Korthals, Nina Sehnke, Ralf Kronenwett, Thomas Schroeder,
Tobias Strapatsas, Guido Kobbe, Rainer Haas, Roland Fenk1116 Trends in Use of and Survival after Autologous Hematopoietic
Cell Transplantation in North America, 1995-2005: Significant
Improvement in Survival for Lymphoma and Myeloma during
a Period of Increasing Recipient Age
Philip L. McCarthy Jr., Theresa Hahn, Anna Hassebroek, Christopher Bredeson,
James Gajewski, Gregory Hale, Luis Isola, Hillard M. Lazarus,
Stephanie J. Lee, Charles F. LeMaistre, Fausto Loberiza,
Richard T. Maziarz, J. Douglas Rizzo, Steven Joffe, Susan Parsons,
Navneet S. MajhailBRIEF ARTICLES
1124 Nelarabine for T Cell Acute Lymphoblastic Leukemia Relapsing after
Allogeneic Hematopoietic Stem Cell Transplantation: An
Opportunity to Improve Survival
Edouard Forcade, Thibaut Leguay, Norbert Vey, Andre Baruchel, Jacques Delaunay,
Marie Robin, Gerard Socie, Herve Dombret, Regis Peffault de Latour,
Emmanuel RaffouxContinued
Contents, continued1126 Autologous Umbilical Cord Blood Infusion followed by Oral
Docosahexaenoic Acid and Vitamin D Supplementation for
C-Peptide Preservation in Children with Type 1 Diabetes
Michael J. Haller, Clive H. Wasserfall, Maigan A. Hulme, Miriam Cintron,
Todd M. Brusko, Keiran M. McGrail, John R. Wingard, Douglas W. Theriaque,
Jonathan J. Shuster, Ronald J. Ferguson, Marianne Kozuch, Michael Clare-Salzler,
Mark A. Atkinson, Desmond A. Schatz1129 Extracorporeal Photopheresis versus Anticytokine Therapy
as a Second-Line Treatment for Steroid-Refractory Acute
GVHD: A Multicenter Comparative Analysis
Madan Jagasia, Hildegard Greinix, Marie Robin, Emma Das-Gupta,
Ryan Jacobs, Bipin N. Savani, Brian G. Engelhardt, Adetola Kassim,
Nina Worel, Robert Knobler, Nigel Russell, Gerard Socie1133 Salvage Bone Marrow Harvest in Patients Failing Plerixafor-Based
Stem Cell Mobilization Attempt: Feasibility and Autologous
Transplantation Outcomes
Abraham S. Kanate, Kathy Watkins, Aaron Cumpston, Michael Craig,
Mehdi HamadaniASBMT NEWS
1136 ASBMT News
